The Prevalence and Cost of Advanced Nonalcoholic Steatohepatitis in Ontario

Summary

Client: IQVIA Solutions Canada Inc.

Project ID: P2018-044 / 2019 0970 155 000

Research Question/Objectives: Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD), a condition where fat builds up in a patient’s liver. As steatosis continues, inflammation and fibrosis develop. If advanced, NASH can cause complications such as cirrhosis and portal hypertension. Left untreated, liver transplantation due to liver failure may be required.

Research objectives:

• To describe the prevalence of type 2 diabetes with chronic kidney disease in Ontario.
• To determine the cost to the Ontario healthcare system to treat type 2 diabetes with chronic kidney disease.

Status: Completed

Results:

• March 2021